Active, not recruitingPhase 1NCT03030066

Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

Studying Glial tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Daiichi Sankyo
Principal Investigator
Global Clinical Leader
Daiichi Sankyo
Intervention
DS-1001b(drug)
Enrollment
47 enrolled
Eligibility
20 years · All sexes
Timeline
20172026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03030066 on ClinicalTrials.gov

Other trials for Glial tumor

Additional recruiting or active studies for the same condition.

See all trials for Glial tumor

← Back to all trials